Literature DB >> 21880073

A nationwide cohort study of the risk of chronic obstructive pulmonary disease in coeliac disease.

J F Ludvigsson1, M Inghammar, M Ekberg, A Egesten.   

Abstract

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) continues to be an important cause of morbidity, mortality and healthcare costs in the western world. Although smoking is an important trigger of COPD, other factors such as chronic inflammation and malnutrition are known to influence its development. Because coeliac disease (CD) is characterized both by dysregulated inflammation and malnutrition, the possibility of an association between CD and COPD was investigated.
METHODS: Through biopsy data from all Swedish pathology departments, we identified 10 990 individuals with CD who were biopsied between 1987 and 2008 (Marsh 3: villous atrophy). As controls, 54 129 reference individuals matched for age, sex, county and calendar year of first biopsy were selected. Cox regression analysis was then performed to estimate hazard ratios (HRs) for having a diagnosis of COPD according to the Swedish Patient Register.
RESULTS: During follow-up, 380 individuals with CD (3.5%) and 1391 (2.6%) controls had an incident diagnosis of COPD, which corresponds to an HR of 1.24 (95% CI: 1.10-1.38) and an excess risk of COPD of 79/100 000 person-years in CD. The risk increase remained 5 years after biopsy (HR = 1.17; 95% CI: 1.00-1.37). Risk estimates did not change with adjustment for type 1 diabetes, thyroid disease, rheumatoid arthritis, country of birth or level of education. Men with CD were at a higher risk of COPD (HR = 1.39; 95% CI: 1.18-1.62) than women with CD (HR = 1.11; 95% CI: 0.94-1.30). Of note, CD was also associated with COPD before CD diagnosis (odds ratio = 1.22; 95% CI: 1.02-1.46). Conclusion.  Patients with CD seem to be at a moderately increased risk of COPD both before and after CD diagnosis.
© 2011 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Mesh:

Year:  2011        PMID: 21880073     DOI: 10.1111/j.1365-2796.2011.02448.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  5 in total

1.  Direct Costs in Patients with Celiac Disease in the USA: A Retrospective Claims Analysis.

Authors:  Stefano Guandalini; Namita Tundia; Roopal Thakkar; Dendy Macaulay; Kirk Essenmacher; Mahesh Fuldeore
Journal:  Dig Dis Sci       Date:  2016-07-14       Impact factor: 3.199

Review 2.  Celiac Disease: Extraintestinal Manifestations and Associated Conditions.

Authors:  Amelie Therrien; Ciaran P Kelly; Jocelyn A Silvester
Journal:  J Clin Gastroenterol       Date:  2020-01       Impact factor: 3.174

3.  Normal Gastrointestinal Mucosa at Biopsy and Overall Mortality: Nationwide Population-Based Cohort Study.

Authors:  Jonas F Ludvigsson; Jiangwei Sun; Ola Olén; Mingyang Song; Jonas Halfvarson; Bjorn Roelstraete; Hamed Khalili; Fang Fang
Journal:  Clin Epidemiol       Date:  2022-07-21       Impact factor: 5.814

4.  Normal gastrointestinal mucosa at biopsy and subsequent cancer risk: nationwide population-based, sibling-controlled cohort study.

Authors:  Jiangwei Sun; Fang Fang; Ola Olén; Mingyang Song; Jonas Halfvarson; Bjorn Roelstraete; Hamed Khalili; Jonas F Ludvigsson
Journal:  BMC Cancer       Date:  2022-08-13       Impact factor: 4.638

5.  Modified dachengqi decoction combined with conventional treatment for treating acute exacerbation of chronic obstructive pulmonary disease: a systematic review based on randomized controlled trials.

Authors:  Ruohan Wu; Zheng Fengjie; Yuhang Li; Sun Yan; Liu Miao; Wang Tan; Zhang Jinchao
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-03       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.